These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 30565086)

  • 1. SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018).
    González Del Alba A; De Velasco G; Lainez N; Maroto P; Morales-Barrera R; Muñoz-Langa J; Pérez-Valderrama B; Basterretxea L; Caballero C; Vazquez S
    Clin Transl Oncol; 2019 Jan; 21(1):64-74. PubMed ID: 30565086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.
    Milowsky MI; Rumble RB; Booth CM; Gilligan T; Eapen LJ; Hauke RJ; Boumansour P; Lee CT
    J Clin Oncol; 2016 Jun; 34(16):1945-52. PubMed ID: 27001593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021).
    Valderrama BP; González-Del-Alba A; Morales-Barrera R; Peláez Fernández I; Vázquez S; Caballero Díaz C; Domènech M; Fernández Calvo O; Gómez de Liaño Lista A; Arranz Arija JÁ
    Clin Transl Oncol; 2022 Apr; 24(4):613-624. PubMed ID: 35347572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.
    Witjes JA; Compérat E; Cowan NC; De Santis M; Gakis G; Lebret T; Ribal MJ; Van der Heijden AG; Sherif A;
    Eur Urol; 2014 Apr; 65(4):778-92. PubMed ID: 24373477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).
    Lázaro M; Gallardo E; Doménech M; Pinto Á; González-del-Alba A; Del Alba AG; Puente J; Fernández O; Font A; Lainez N; Vázquez S
    Clin Transl Oncol; 2016 Dec; 18(12):1197-1205. PubMed ID: 27900539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma.
    Nadal R; Apolo AB
    Curr Treat Options Oncol; 2018 May; 19(7):36. PubMed ID: 29808294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.
    Witjes JA; Bruins HM; Cathomas R; Compérat EM; Cowan NC; Gakis G; Hernández V; Linares Espinós E; Lorch A; Neuzillet Y; Rouanne M; Thalmann GN; Veskimäe E; Ribal MJ; van der Heijden AG
    Eur Urol; 2021 Jan; 79(1):82-104. PubMed ID: 32360052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.
    Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
    Eur Urol; 2011 Jun; 59(6):1009-18. PubMed ID: 21454009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines].
    Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
    Actas Urol Esp; 2012 Sep; 36(8):449-60. PubMed ID: 22386114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEOM clinical guidelines for the treatment of invasive bladder cancer.
    Morales R; Font A; Carles J; Isla D
    Clin Transl Oncol; 2011 Aug; 13(8):552-9. PubMed ID: 21821489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant therapy for muscle-invasive bladder cancer.
    Jain RK; Sonpavde G
    Expert Rev Anticancer Ther; 2020 Jul; 20(7):603-614. PubMed ID: 32546025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Approaches for Cisplatin-Ineligible Patients with Invasive Bladder Cancer.
    Einstein DJ; Sonpavde G
    Curr Treat Options Oncol; 2019 Feb; 20(2):12. PubMed ID: 30741358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an
    Satkunasivam R; Lim K; Teh BS; Guzman J; Zhang J; Farach A; Chen SH; Wallis CJ; Efstathiou E; Esnaola NF; Sonpavde GP
    Future Oncol; 2022 Aug; 18(25):2771-2781. PubMed ID: 35703113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer.
    Leow JJ; Bedke J; Chamie K; Collins JW; Daneshmand S; Grivas P; Heidenreich A; Messing EM; Royce TJ; Sankin AI; Schoenberg MP; Shipley WU; Villers A; Efstathiou JA; Bellmunt J; Stenzl A
    World J Urol; 2019 Jan; 37(1):61-83. PubMed ID: 30684034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the management of muscle-invasive bladder cancer through risk prediction, risk communication, and novel treatment approaches.
    Galsky MD; Domingo-Domenech J
    Clin Adv Hematol Oncol; 2013 Feb; 11(2):86-92. PubMed ID: 23598909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary Management of Muscle-Invasive Bladder Cancer: Current Challenges and Future Directions.
    Aragon-Ching JB; Werntz RP; Zietman AL; Steinberg GD
    Am Soc Clin Oncol Educ Book; 2018 May; 38():307-318. PubMed ID: 30231340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for bladder cancer.
    Sonpavde G; Lerner SP
    Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology].
    Pignot G; Houédé N; Roumiguié M; Audenet F; Brunelle S; Colin P; Compérat E; Larré S; Masson-Lecomte A; Neuzillet Y; Xylinas E; Méjean A; Rouprêt M;
    Prog Urol; 2018 Oct; 28(12):567-574. PubMed ID: 30205925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma].
    Stenzl A; Cowan NC; De Santis M; Jakse G; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
    Actas Urol Esp; 2010 Jan; 34(1):51-62. PubMed ID: 20223133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative therapy for muscle invasive bladder cancer.
    Leow JJ; Fay AP; Mullane SA; Bellmunt J
    Hematol Oncol Clin North Am; 2015 Apr; 29(2):301-18, ix. PubMed ID: 25836936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.